Fifth Third Bancorp
AXSM icon

Fifth Third Bancorp’s Axsome Therapeutics AXSM Stock Holding History

Fifth Third Bancorp’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.08M Buy
24,836
+8,622
+53% +$1.87M 0.01% 691
2026
Q1 		$2.74M Buy
16,214
+13,737
+555% +$2.37M 0.01% 1057
2025
Q4 		$452K Buy
2,477
+2,265
+1,068% +$316K ﹤0.01% 798
2025
Q3 		$25.7K Buy
212
+12
+6% +$1.35K ﹤0.01% 1783
2025
Q2 		$20.9K Hold
200
– – ﹤0.01% 1762
2025
Q1 		$23.3K Hold
200
– – ﹤0.01% 1707
2024
Q4 		$16.9K Hold
200
– – ﹤0.01% 1803
2024
Q3 		$18K Hold
200
– – ﹤0.01% 1808
2024
Q2 		$16.1K Hold
200
– – ﹤0.01% 1778
2024
Q1 		$16K Hold
200
– – ﹤0.01% 1724
2023
Q4 		$15.9K Sell
200
-200
-50% -$13.4K ﹤0.01% 1836
2023
Q3 		$28K Buy
400
+200
+100% +$15K ﹤0.01% 1609
2023
Q2 		$14.4K Hold
200
– – ﹤0.01% 1856
2023
Q1 		$12.3K Hold
200
– – ﹤0.01% 2019
2022
Q4 		$15.4K Hold
200
– – ﹤0.01% 1801
2022
Q3 		$9K Hold
200
– – ﹤0.01% 1969
2022
Q2 		$8K Buy
+200
New +$6.33K ﹤0.01% 2068

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fifth Third Bancorp's AXSM Position: Q2 2026 in Review

Fifth Third Bancorp increased its Axsome Therapeutics (AXSM) stake by 53% in Q2 2026, buying an estimated $1.87M and bringing the position to 24,836 shares worth $6.08M. The position accounts for 0.01% of the portfolio, ranked #691.

Fifth Third Bancorp first reported a position in AXSM in Q2 2022 and has held it in 17 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Fifth Third Bancorp held 24,836 shares of Axsome Therapeutics worth $6.08M as of Q2 2026.
  • Fifth Third Bancorp bought 8,622 Axsome Therapeutics shares in Q2 2026, an estimated $1.87M.
  • Axsome Therapeutics made up 0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #691 holding.
  • Fifth Third Bancorp first reported a position in Axsome Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.